Sotorasib Plus Panitumumab Provides Effective Targeted Therapy Option in KRAS G12C+ mCRC
Marwan G. Fakih, MD, discusses the FDA approval of sotorasib plus panitumumab in KRAS G12C–mutated metastatic colorectal cancer.
Related Articles
Dr McNall-Knapp on HRQOL Outcomes With Mirdametinib in NF1-PN
Rene Y. McNall-Knapp, MD, discusses HRQOL outcomes from the ReNeu trial investigating mirdametinib in patients with NF1-PN.
2024 Hot Topic in Basic & Translational Science Conference Highlights | IASLC
IASLC presents a one-hour, live session focused on key highlights from the 2024 Hot Topic in Basic & Translational Science Conference. This webinar will…
Welcome! You are invited to join a webinar: SSO CGSO Videoconference: Melanoma. After registering, you will receive a confirmation email about joining the webinar.
SSO sponsors educational videoconferences for CGSO Fellows, Residents, and faculty. This session will discuss the management of melanoma in both the localized and metastatic setting.…
Fox Chase Cancer Center’s Lilian J. Shin-Cho Selected as American Psychosocial Oncology Society 2025 Health Equity Scholar
PHILADELPHIA (January 31, 2025) — Lilian J. Shin-Cho, PhD, an Assistant Professor in the Cancer Prevention and Control Research Program at Fox Chase Cancer Center,…
Cytoreductive Therapy in PV Treatment Paradigm
Panelists discuss how cytoreductive therapy fits into the treatment paradigm for polycythemia vera (PV), highlighting key findings from the CYTO-PV study and its subanalysis, which…
Getting the Full Story: The Importance of Ultra-Comprehensive Genomic Profiling in Advanced Cancer Therapy Selection
It’s difficult to imagine starting a cancer treatment path for a patient without first reviewing their molecular test results. This means getting the comprehensive story…
FDA approves mirdametinib for adult and pediatric patients with neurof
On February 11, 2025, the Food and Drug Administration approved mirdametinib (Gomekli, SpringWorks Therapeutics, Inc.), a kinase inhibitor, for adult and pediatric patients 2 years…
Pediatric Track offers timely updates on complex conditions in children – Tandem Meetings News
A full day of programming is dedicated to the tailored treatments that are required to care for this uniquely vulnerable patient population, explains Michael Verneris,…
Reprogramming Compromised Immune Cells to Fight Cancer – News Center
Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to work against tumors, according to a study published in Science Advances.
